Healthcare -
Biotechnology - NASDAQ - US
$ 52.8
-18.3 %
$ 2.91 B
Market Cap
-26.4
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Arcellx, Inc.
| Revenue | 108 M |
| Cost Of Revenue | 5.19 M |
| Gross Profit | 103 M |
| Operating Expenses | 246 M |
| Operating Income | -138 M |
| Other Expenses | -30.2 M |
| Net Income | -107 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 107.9 | 110.3 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 5.2 | 0 | 2.2 | 1.0 | 0.6 | 0.3 | 0 |
| Gross Profit | 102.7 | 110.3 | (2.2) | (1.0) | (0.6) | (0.3) | 0 |
| OPERATING INCOME | |||||||
| Operating Expenses | 245.5 | 200.2 | 191.3 | 65.0 | 32.1 | 18.0 | 8.3 |
| Selling, General and Administrative Expenses | 88.4 | 66.3 | 41.7 | 18.1 | 7.0 | 2.2 | 2.2 |
| Research and Development Expenses | 157.1 | 133.8 | 149.6 | 46.9 | 25.1 | 15.8 | 6.1 |
| Operating Income | (137.6) | (89.9) | (191.3) | (65.0) | (32.1) | (18.0) | (8.3) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 1.0 | 3.8 | 1.7 | 10 K | 0 | 0 | 0 |
| Total Other Income | 32.3 | 19.9 | 2.6 | 49 K | 1 K | 2 K | 999 |
| Pre-Tax Income | (105.3) | (70.0) | (188.7) | (65.0) | (32.1) | (18.0) | (8.3) |
| NET INCOME | |||||||
| Tax Provision | 2.1 | 0.7 | (2.6) | (1.0) | 0.4 | 0.2 | 0 |
| Net Income | (107.3) | (70.7) | (186.1) | (63.9) | (32.1) | (18.0) | (8.3) |
| EPS | 2 | 1.47 | 4.22 | 1.91 | 1.47 | 0.52 | 50.2 |